| NCT03222687 |
Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis |
https://ClinicalTrials.gov/show/NCT03222687 |
Completed |
Shandong University |
2017-05-31 |
| NCT03214731 |
Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT03214731 |
Recruiting |
Sun Yat-sen University |
2020-11-01 |
| NCT03200002 |
Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT03200002 |
Completed |
Chitwan Medical College |
2015-06-30 |
| NCT03174587 |
Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT03174587 |
Completed |
Corestem, Inc. |
2019-03-12 |
| NCT03031925 |
Detection of Annexin A2 in Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT03031925 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2018-11-09 |
| NCT03021499 |
Aurinia Renal Response in Active Lupus With Voclosporin |
https://ClinicalTrials.gov/show/NCT03021499 |
Completed |
Aurinia Pharmaceuticals Inc. |
2019-09-24 |
| NCT02954939 |
The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02954939 |
Recruiting |
The University of Hong Kong |
2021-03-31 |
| NCT02949973 |
Aurinia Early Urinary Protein Reduction Predicts Response |
https://ClinicalTrials.gov/show/NCT02949973 |
Completed |
Aurinia Pharmaceuticals Inc. |
2016-12-31 |
| NCT02949349 |
Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02949349 |
Completed |
Genovate Biotechnology Co., Ltd., |
2016-12-30 |
| NCT02936375 |
The Iguratimod Effect on Lupus Nephritis (IGeLU) |
https://ClinicalTrials.gov/show/NCT02936375 |
Recruiting |
RenJi Hospital |
2020-11-30 |
| NCT02770170 |
Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02770170 |
Active, not recruiting |
Boehringer Ingelheim |
2019-12-24 |
| NCT02682407 |
Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 |
https://ClinicalTrials.gov/show/NCT02682407 |
Recruiting |
Omeros Corporation |
2020-12-31 |
| NCT02645565 |
Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02645565 |
Completed |
Jawaharlal Institute of Postgraduate Medical Education & Research |
2016-12-31 |
| NCT02630628 |
Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02630628 |
Recruiting |
The University of Hong Kong |
2022-12-31 |
| NCT01639339 |
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01639339 |
Completed |
GlaxoSmithKline |
2019-07-25 |
| NCT03393013 |
A Study of KZR-616 in Patients With Systemic Lupus Erythematosus With and Without Nephritis |
https://ClinicalTrials.gov/show/NCT03393013 |
Recruiting |
Kezar Life Sciences, Inc. |
2021-06-30 |
| NCT02547922 |
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02547922 |
Active, not recruiting |
AstraZeneca |
2019-11-26 |
| NCT02532790 |
The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children |
https://ClinicalTrials.gov/show/NCT02532790 |
Recruiting |
Nanjing Children’s Hospital |
2020-07-31 |
| NCT02532777 |
The Research of Standard Diagnosis and Treatment for HSPN in Children |
https://ClinicalTrials.gov/show/NCT02532777 |
Recruiting |
Nanjing Children’s Hospital |
2020-07-31 |
| NCT02457221 |
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02457221 |
Completed |
Astellas Pharma Inc |
2018-09-10 |
| NCT02260934 |
Rituximab and Belimumab for Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02260934 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2018-03-12 |
| NCT03385564 |
An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT03385564 |
Recruiting |
Boehringer Ingelheim |
2022-10-31 |
| NCT02226341 |
ACTHar in the Treatment of Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02226341 |
Recruiting |
Columbia University |
2024-01-31 |
| NCT02141672 |
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV) |
https://ClinicalTrials.gov/show/NCT02141672 |
Completed |
Aurinia Pharmaceuticals Inc. |
2016-07-31 |
| NCT01312727 |
Hereditary Tubulointerstitial Nephritis |
https://ClinicalTrials.gov/show/NCT01312727 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2014-02-28 |
| NCT01273389 |
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01273389 |
Completed |
Janssen Research & Development, LLC |
2013-09-30 |
| NCT01714817 |
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01714817 |
Completed |
Bristol-Myers Squibb |
2016-11-21 |
| NCT01580865 |
Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01580865 |
Completed |
Ramathibodi Hospital |
2017-03-31 |
| NCT01328834 |
Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01328834 |
Completed |
Sun Yat-sen University |
2011-10-31 |
| NCT04376216 |
Prednisolone Treatment in Acute Interstitial Nephritis |
https://ClinicalTrials.gov/show/NCT04376216 |
Recruiting |
Region MidtJylland Denmark |
2026-09-01 |
| NCT04318600 |
Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT04318600 |
Completed |
Yan’an Affiliated Hospital of Kunming Medical University |
2017-03-01 |
| NCT04146220 |
Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT04146220 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2019-09-30 |
| NCT04128579 |
Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis |
https://ClinicalTrials.gov/show/NCT04128579 |
Recruiting |
Equillium |
2021-06-30 |
| NCT03943147 |
An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT03943147 |
Recruiting |
Bristol-Myers Squibb |
2023-01-27 |
| NCT03920059 |
Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT03920059 |
Recruiting |
Chulalongkorn University |
2025-04-30 |
| NCT03828071 |
Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT03828071 |
Completed |
Nanjing University School of Medicine |
2015-01-01 |
| NCT03664908 |
Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)? |
https://ClinicalTrials.gov/show/NCT03664908 |
Completed |
CHU de Reims |
2019-04-04 |
| NCT03610516 |
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis. |
https://ClinicalTrials.gov/show/NCT03610516 |
Recruiting |
Novartis |
2021-03-17 |
| NCT03597464 |
Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin |
https://ClinicalTrials.gov/show/NCT03597464 |
Recruiting |
Aurinia Pharmaceuticals Inc. |
2021-08-31 |
| NCT03453619 |
Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies |
https://ClinicalTrials.gov/show/NCT03453619 |
Active, not recruiting |
Apellis Pharmaceuticals, Inc. |
2020-04-30 |
| NCT01207297 |
Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01207297 |
Completed |
Zhejiang University |
2010-03-31 |
| NCT01206569 |
Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01206569 |
Completed |
Chinese University of Hong Kong |
2011-12-31 |
| NCT01203709 |
Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01203709 |
Completed |
Tuen Mun Hospital |
2012-12-31 |
| NCT01085097 |
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01085097 |
Completed |
Teva Pharmaceutical Industries |
2012-09-30 |
| NCT01056237 |
Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01056237 |
Completed |
Nanjing University School of Medicine |
2013-06-30 |
| NCT01042457 |
Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT01042457 |
Completed |
Chulalongkorn University |
2011-12-31 |
| NCT00976300 |
Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study |
https://ClinicalTrials.gov/show/NCT00976300 |
Completed |
Institute of Rheumatology, Prague |
2008-05-31 |
| NCT00935389 |
Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria |
https://ClinicalTrials.gov/show/NCT00935389 |
Completed |
Nanjing University School of Medicine |
2011-04-30 |
| NCT00881309 |
To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00881309 |
Completed |
Nanjing University School of Medicine |
2011-04-30 |
| NCT00876616 |
Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00876616 |
Completed |
Nanjing University School of Medicine |
2011-05-31 |
| NCT02550652 |
A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN) |
https://ClinicalTrials.gov/show/NCT02550652 |
Active, not recruiting |
Hoffmann-La Roche |
2019-01-15 |
| NCT02256150 |
A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT02256150 |
Completed |
Asahi Kasei Pharma Corporation |
2019-03-31 |
| NCT00774852 |
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00774852 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-12-31 |
| NCT00709722 |
Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00709722 |
Completed |
Nippon Kayaku Co., Ltd. |
2007-04-30 |
| NCT00705367 |
Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg |
https://ClinicalTrials.gov/show/NCT00705367 |
Completed |
Bristol-Myers Squibb |
2009-01-31 |
| NCT00626197 |
A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) |
https://ClinicalTrials.gov/show/NCT00626197 |
Completed |
Genentech, Inc. |
2009-10-31 |
| NCT00615173 |
Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00615173 |
Completed |
Sun Yat-sen University |
2008-09-30 |
| NCT00429377 |
Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study |
https://ClinicalTrials.gov/show/NCT00429377 |
Completed |
Astellas Pharma Inc |
NA |
| NCT00423098 |
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare |
https://ClinicalTrials.gov/show/NCT00423098 |
Completed |
Novartis |
2009-11-30 |
| NCT00404794 |
A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00404794 |
Completed |
Hospital Authority, Hong Kong |
NA |
| NCT00377637 |
A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. |
https://ClinicalTrials.gov/show/NCT00377637 |
Completed |
Hoffmann-La Roche |
2007-03-31 |
| NCT00371319 |
Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00371319 |
Completed |
Tuen Mun Hospital |
2014-05-31 |
| NCT00302549 |
To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN |
https://ClinicalTrials.gov/show/NCT00302549 |
Completed |
Nanjing University School of Medicine |
2005-05-31 |
| NCT00301613 |
Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN |
https://ClinicalTrials.gov/show/NCT00301613 |
Completed |
Nanjing University School of Medicine |
2005-05-31 |
| NCT00298506 |
Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V) |
https://ClinicalTrials.gov/show/NCT00298506 |
Completed |
Nanjing University School of Medicine |
2008-12-31 |
| NCT00282347 |
A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00282347 |
Completed |
Genentech, Inc. |
2009-01-31 |
| NCT00268567 |
Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone |
https://ClinicalTrials.gov/show/NCT00268567 |
Completed |
Peking University |
NA |
| NCT00204022 |
Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis. |
https://ClinicalTrials.gov/show/NCT00204022 |
Completed |
Université Catholique de Louvain |
2011-08-31 |
| NCT00125307 |
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis |
https://ClinicalTrials.gov/show/NCT00125307 |
Completed |
Chinese University of Hong Kong |
2007-10-31 |
| NCT00094380 |
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) |
https://ClinicalTrials.gov/show/NCT00094380 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-01-31 |
| NCT00818948 |
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis |
https://ClinicalTrials.gov/show/NCT00818948 |
Completed |
Amgen |
2014-06-30 |
| NCT00001789 |
BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00001789 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00035308 |
Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease |
https://ClinicalTrials.gov/show/NCT00035308 |
Completed |
La Jolla Pharmaceutical Company |
NA |
| NCT00001676 |
Cyclophosphamide and Fludarabine to Treat Lupus Nephritis |
https://ClinicalTrials.gov/show/NCT00001676 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |